A morphological explanation of the transmission defect in myasthenia gravis.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001001:Anura; D002415:Cats; D002794:Choline / Q000494:pharmacology; D003650:Decamethonium Compounds / Q000494:pharmacology; D004285:Dogs; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D008564:Membrane Potentials; D009157:Myasthenia Gravis / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D009411:Nerve Endings / Q000473:pathology; D009416:Nerve Regeneration; D009469:Neuromuscular Junction / Q000473:pathology*; D011789:Quantum Theory; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013569:Synapses / Q000503:physiopathology; D009435:Synaptic Transmission; D013950:Thymus Gland / Q000473:pathology / Q000503:physiopathology
D003650:Decamethonium Compounds; D002794:Choline; D000109:Acetylcholine